Correlation Between Regeneron Pharmaceuticals and Kellanova

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Kellanova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Kellanova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Kellanova, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Kellanova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Kellanova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Kellanova.

Diversification Opportunities for Regeneron Pharmaceuticals and Kellanova

-0.61

Correlation Coefficient

Regeneron Pharmaceuticals  Kellanova

Excellent diversification

The 3 months correlation between Regeneron and Kellanova is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Kellanova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kellanova and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Kellanova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kellanova has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Kellanova go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Kellanova

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Kellanova. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.09 times less risky than Kellanova. The stock trades about -0.19 of its potential returns per unit of risk. The Kellanova is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  5,574  in Kellanova on October 10, 2024 and sell it today you would earn a total of  2,561  from holding Kellanova or generate 45.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Kellanova

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kellanova

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Kellanova are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward-looking signals, Kellanova is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Regeneron Pharmaceuticals and Kellanova

The main advantage of trading using opposite Regeneron Pharmaceuticals and Kellanova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Kellanova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kellanova will offset losses from the drop in Kellanova's long position.

The idea behind Regeneron Pharmaceuticals and Kellanova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.